Adesis, Inc., a leading contract research organization and a wholly-owned subsidiary of Universal Display, announced that Linda Choi MacDonald has joined the company as COO. MacDonald brings more than 25 years of experience in the biopharmaceutical industry, including leading organizations in the Americas, Europe and Asia-Pacific regions. As COO, MacDonald is responsible for overseeing Adesis’ P&L, operations and strategy.

“Adding Linda’s breadth of commercial, R&D and G&A experience and her international background in the biopharmaceutical industry to our extraordinary chemistry and leadership teams is expected to expand our expertise as a world-class CRO,” said Andrew Cottone, Ph.D., President of Adesis, Inc.

Prior to joining Adesis, MacDonald served as COO at Avanir Pharmaceuticals, a subsidiary of Otsuka Pharmaceutical. Previously, she was VP of global marketing & patient access operations, VP of talent services Asia Pacific, and head of global customer-facing excellence strategy & operations at UCB Biopharma, and held various positions of increasing responsibility at Eli Lilly and Company across its commercial organizations.

Her track record of success led her to be recognized as a 2020 HBA (Healthcare Businesswomen's Association) Luminary Award recipient for being a “shining example of transformational leadership.”